Human IL-18 R alpha/IL-1 R5 Antibody, R&D Systems™

IL-18R alpha/IL-1 R5

Monoclonal

Unconjugated

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative

IL18R1

Mouse myeloma cell line NS0-derived recombinant human IL-18 R alpha/IL-1 R5 Glu20-Arg329 Accession # Q13478

500 μg

Primary

Detects Recombinant Human IL-18 R alpha/IL-1 R5 in direct ELISAs. In direct ELISAs, no cross-reactivity with recombinant human (rh) IL-1 RI, rhIL-1 RII, rhIL-1 R3, rhIL-1 R4, rhIL-1 R6, rhIL-1 R7, rhIL-1 R8, rhIL-1 R9, rhSIGIRR or recombinant mouse IL-18 R alpha is observed.

Human

Supernatant

Flow Cytometry, Immunohistochemistry, Neutralization, Immunocytochemistry, CyTOF

70625

Flow Cytometry 2.5 ug/10^6 cells, Immunohistochemistry 8-25 ug/mL, Neutralization 0.03-0.1 ug/mL, Immunocytochemistry 8-25 ug/mL, CyTOF-ready

Q13478

Mouse

Protein A or G purified from hybridoma culture supernatant

RUO

8809

Reconstitute at 0.5 mg/mL in sterile PBS.

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.

IgG1